BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16052228)

  • 21. Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase.
    Ceppi P; Volante M; Saviozzi S; Rapa I; Novello S; Cambieri A; Lo Iacono M; Cappia S; Papotti M; Scagliotti GV
    Cancer; 2006 Oct; 107(7):1589-96. PubMed ID: 16955506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Suppression of telomerase activity by plasmid-mediated RNA interference].
    Li Y; Li M; Peng Y; Jiang Z; Li W; Li H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):615-9. PubMed ID: 16856401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antisense targeting of thymidylate synthase (TS) mRNA increases TS gene transcription and TS protein: effects on human tumor cell sensitivity to TS enzyme-inhibiting drugs.
    Jason TL; Berg RW; Vincent MD; Koropatnick J
    Gene Expr; 2007; 13(4-5):227-39. PubMed ID: 17605297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis.
    Fukui Y; Oka T; Nagayama S; Danenberg PV; Danenberg KD; Fukushima M
    Int J Mol Med; 2008 Dec; 22(6):709-16. PubMed ID: 19020767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A naturally occurring tyrosine to histidine replacement at residue 33 of human thymidylate synthase confers resistance to 5-fluoro-2'-deoxyuridine in mammalian and bacterial cells.
    Barbour KW; Hoganson DK; Berger SH; Berger FG
    Mol Pharmacol; 1992 Aug; 42(2):242-8. PubMed ID: 1355260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complex transcriptional initiation pattern of the thymidylate synthase promoter in mouse tissues.
    Lee Y; Shen G; Johnson LF
    Arch Biochem Biophys; 1999 Dec; 372(2):389-92. PubMed ID: 10600180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inhibition of invasive and chemotactic abilities of SKOV3 cells by human epithelial growth receptor-2 small interfering RNA].
    Zhang SL; Lu YM; Meng LR; Zhao YY
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):48-53. PubMed ID: 17331422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach.
    Tao J; Tu YT; Huang CZ; Feng AP; Wu Q; Lian YJ; Zhang LX; Zhang XP; Shen GX
    Br J Dermatol; 2005 Oct; 153(4):715-24. PubMed ID: 16181451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ODN 491, a novel antisense oligodeoxynucleotide that targets thymidylate synthase, exerts cell-specific effects in human tumor cell lines.
    Jason TL; Figueredo R; Ferguson PJ; Vincent MD; Berg RW; Koropatnick J
    DNA Cell Biol; 2008 May; 27(5):229-40. PubMed ID: 18358073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of thymidylate synthase gene expression level in patients with adenocarcinoma of the lung.
    Hashimoto H; Ozeki Y; Sato M; Obara K; Matsutani N; Nakagishi Y; Ogata T; Maehara T
    Cancer; 2006 Apr; 106(7):1595-601. PubMed ID: 16489621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA.
    Yamato K; Fen J; Kobuchi H; Nasu Y; Yamada T; Nishihara T; Ikeda Y; Kizaki M; Yoshinouchi M
    Cancer Gene Ther; 2006 Mar; 13(3):234-41. PubMed ID: 16138119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells.
    Wu RH; Cheng TL; Lo SR; Hsu HC; Hung CF; Teng CF; Wu MP; Tsai WH; Chang WT
    J Gene Med; 2007 Jul; 9(7):620-34. PubMed ID: 17486668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells.
    de Souza Nascimento P; Alves G; Fiedler W
    Oncol Rep; 2006 Aug; 16(2):423-8. PubMed ID: 16820926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The means to an end of tumor cell resistance to chemotherapeutic drugs targeting thymidylate synthase: shoot the messenger.
    Berg RW; Ferguso PJ; DeMoor JM; Vincen MD; Koropatnick J
    Curr Drug Targets; 2002 Aug; 3(4):297-309. PubMed ID: 12102601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of retinoblastoma tumor suppressor activity by RNA interference in lung cancer lines.
    Reed MF; Zagorski WA; Howington JA; Zilfou JT; Knudsen ES
    Ann Thorac Surg; 2006 Jul; 82(1):249-53. PubMed ID: 16798224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional identity of the active sites of crustacean and viral thymidylate synthases.
    Arvizu-Flores AA; Aispuro-Hernandez E; Garcia-Orozco KD; Varela-Romero A; Valenzuela-Soto E; Velazquez-Contreras EF; Rojo-Domínguez A; Yepiz-Plascencia G; Maley F; Sotelo-Mundo RR
    Comp Biochem Physiol C Toxicol Pharmacol; 2009 Sep; 150(3):406-13. PubMed ID: 19559812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of siRNAs in combination with Gleevec on K-562 cell proliferation and Bcr-Abl expression.
    Baker BE; Kestler DP; Ichiki AT
    J Biomed Sci; 2006 Jul; 13(4):499-507. PubMed ID: 16547768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fundamental study of small interfering RNAs for ganglioside GD3 synthase gene as a therapeutic target of lung cancers.
    Ko K; Furukawa K; Takahashi T; Urano T; Sanai Y; Nagino M; Nimura Y; Furukawa K
    Oncogene; 2006 Nov; 25(52):6924-35. PubMed ID: 16862187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of thymidylate synthase as an RNA binding protein.
    Chu E; Allegra CJ
    Bioessays; 1996 Mar; 18(3):191-8. PubMed ID: 8867733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine.
    Correale P; Del Vecchio MT; Di Genova G; Savellini GG; La Placa M; Terrosi C; Vestri M; Urso R; Lemonnier F; Aquino A; Bonmassar E; Giorgi G; Francini G; Cusi MG
    J Natl Cancer Inst; 2005 Oct; 97(19):1437-45. PubMed ID: 16204693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.